APIE Therapeutics Prepares to Advance Pipeline Programs with Appointment of Robert Willette, Ph.D. as Chief Scientific Officer
APIE Therapeutics appoints Robert Willette, Ph.D. to the newly created role of chief scientific officer.
APIE Therapeutics appoints Robert Willette, Ph.D. to the newly created role of chief scientific officer.
© 2020 APIE Therapeutics. All rights reserved